UNIQUE EXPERTISE
Headquartered in Reykjavik, Iceland, deCODE is a global leader in analyzing and understanding the human genome. Using our unique expertise and population resources, deCODE has discovered key genetic risk factors for dozens of common diseases ranging from cardiovascular disease to cancer.
UNIQUE CAPABILITIES
We operate the most productive human gene discovery engine in the world, employing our discoveries to identify genetic variations associated with human disease.
OUR PUBLICATIONS
We regularly publish our discoveries in major, peer-reviewed journals, enabling others to further validate and expand upon our findings.
NEWS
deCODE Breakthrough in Thyroid Cancer May Enable More Targeted Risk Asessment and Earlier Intervention
Reykjavik, ICELAND, February 6, 2009 – Scientists at deCODE genetics (Nasdaq:DCGN) today present the discovery of two single letter variations in the sequence of the human genome (SNPs) conferring substantial increased risk of thyroid cancer. The two SNPs, located on...
deCODEme™ Takes on Heart Disease in February
deCODEme Cardio™ scan offered at $100 during American heart Month; CEO Kari Stefansson to appear on The Martha Stewart Show this Thursday, February 5th Reykjavik, ICELAND, February 3, 2009 – To mark American Heart Month, deCODE genetics (Nasdaq:DCGN) today announced...
Award by the American Society of Human Genetics
At its Annual meeting in October 2017 in Orlando, the American Society of Human Genetics (ASHG), presented Dr. Kári Stefánsson, founder and CEO of deCODE genetics, with the William Allan Award. The award, the top prize given by the society, recognizes a scientist for substantial and far-reaching scientific contributions to human genetics. The ASHG has distributed video footage from the award ceremony. The introduction is given by Professor Mark Daly of Harvard University.